NCT07361991 2026-01-23IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric CancerThe First Affiliated Hospital of Zhengzhou UniversityPhase 1/2 Not yet recruiting50 enrolled